Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0A9UF
|
||||
| Former ID |
DNC013487
|
||||
| Drug Name |
1,2,3,7,12,12a-hexahydro-1-aza-pleiaden-5-ol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528616] | ||
| Formula |
C17H17NO
|
||||
| Canonical SMILES |
C1CNC2CC3=CC=CC=C3CC4=CC(=CC1=C24)O
|
||||
| InChI |
1S/C17H17NO/c19-15-8-13-5-6-18-16-10-12-4-2-1-3-11(12)7-14(9-15)17(13)16/h1-4,8-9,16,18-19H,5-7,10H2
|
||||
| InChIKey |
ZCATUTKNMGBMKU-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Dopamine D1 receptor | Target Info | Inhibitor | [528616] | |
| PANTHER Pathway | Dopamine receptor mediated signaling pathway | ||||
| PathWhiz Pathway | Dopamine Activation of Neurological Reward System | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.